Federal Office for Civil Protection, Spiez Laboratory, Spiez, Switzerland.
ADMed Microbiologie, La-Chaux-de-Fonds, Switzerland.
Swiss Med Wkly. 2021 Dec 10;151:w30120. doi: 10.4414/smw.2021.w30120. eCollection 2021 Dec 6.
The new SARS-CoV-2 Omicron variant (B.1.1.529) has been recently declared a Variant of Concern due to a series of important mutations in the viral spike protein and especially in the receptor-binding domain. While investigations into the spread of this new variant are ongoing, the first cases have been detected in Switzerland. Important questions have been raised: (1) Will the PCR assays commonly used to detect SARS-CoV-2 still work for the Omicron variant? (2) Can specific PCR features, e.g. S-gene dropout, be used to identify potential Omicron samples? In this minireview we provide current knowledge on the Omicron variant and guidance on its PCR validation.
新的 SARS-CoV-2 奥密克戎变异株(B.1.1.529)由于病毒刺突蛋白特别是受体结合域中的一系列重要突变,最近被宣布为关注变异株。虽然对这种新变异株传播的调查仍在进行中,但瑞士已经发现了第一批病例。提出了一些重要的问题:(1)通常用于检测 SARS-CoV-2 的 PCR 检测方法是否仍适用于奥密克戎变异株?(2)是否可以使用特定的 PCR 特征,例如 S 基因缺失,来识别潜在的奥密克戎样本?在这篇综述中,我们提供了奥密克戎变异株的最新知识,并就其 PCR 验证提供了指导。